Ningling Ge
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 5%
- NF-κB Signaling Pathways
Papers in
- Hepatology 19
- Hepatocellular Carcinoma Treatment and Prognosis 19
- Oncology 16
- Cancer Immunotherapy and Biomarkers 5
- Inflammatory Biomarkers in Disease Prognosis 4
- Co-authors
- Zhenggang Ren (17 shared papers)Sheng‐Long Ye (12 shared papers)Jia Fan (13 shared papers)Yanhong Wang (11 shared papers)Lan Zhang (15 shared papers)Boheng Zhang (9 shared papers)Tong‐Chun Xue (8 shared papers)Hui‐Chuan Sun (11 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Journal of Biological Chemistry (3 papers)Annals of Surgical Oncology (3 papers)PLoS ONE (2 papers)Tumor Biology (2 papers)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Ningling Ge
43 papers receiving 1.4k citations
Ningling Ge's Hit Papers
Peers
Comparison fields: 5 of 71
- Hepatology 627
- Cancer Research 279
- Oncology 326
- Immunology 196
- Epidemiology 164
Countries citing papers authored by Ningling Ge
This map shows the geographic impact of Ningling Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ningling Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ningling Ge more than expected).
Fields of papers citing papers by Ningling Ge
This network shows the impact of papers produced by Ningling Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ningling Ge. The network helps show where Ningling Ge may publish in the future.
Co-authors
The 25 scholars most cited alongside Ningling Ge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 215 | |
| 2 | Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations Hit paper breakdown → | 2021 | 163 |
| 3 | 2009 | 150 | |
| 4 | 2014 | 104 | |
| 5 | 2008 | 96 | |
| 6 | 2009 | 80 | |
| 7 | 2014 | 71 | |
| 8 | 2021 | 50 | |
| 9 | 2015 | 45 | |
| 10 | 2015 | 45 | |
| 11 | 2022 | 45 | |
| 12 | 2012 | 45 | |
| 13 | 2015 | 40 | |
| 14 | 2016 | 27 | |
| 15 | 2014 | 26 | |
| 16 | 2021 | 23 | |
| 17 | 2009 | 23 | |
| 18 | 2021 | 23 | |
| 19 | 2015 | 21 | |
| 20 | 2003 | 19 |
About Ningling Ge
Ningling Ge is a scholar working on Hepatology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 45 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Cancer Mechanisms and Therapy (5 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), NF-κB Signaling Pathways (4 papers), Ferroptosis and cancer prognosis (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Hepatology (627 citations), Cancer Research (279 citations), Oncology (326 citations), Immunology (196 citations) and Epidemiology (164 citations). Ningling Ge has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Zhenggang Ren, Sheng‐Long Ye, Jia Fan, Yanhong Wang, Lan Zhang, Boheng Zhang, Tong‐Chun Xue, Hui‐Chuan Sun, Jianhua Yang and Yuan Ji. Their work appears in journals such as Journal of Clinical Oncology, Journal of Biological Chemistry, Annals of Surgical Oncology, PLoS ONE and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.